Fundz

Carna reported raising $3.4 Million in an initial SEC Form D filing, from an offering of $10 Million

PRIVATEFeb 05, 2025$3.4M of $10M raised

Amount Raised

$3.4 Million

$3.4 Million sold, per SEC Form D (first sale Jan 3, 2025)

Round Type

Seed

BostonBiotechnologyHealth CareArtificial IntelligenceMedical

Who else raised in Medical and Biotechnology around the same time

Companies in the same sectors as Carna that raised within 45 days of this round, from Fundz verified event records.

  • Positron raised $24M on February 11, 2025.
  • C the Signs raised $8M (Funding Round) on January 31, 2025.
  • Medow Health raised $2M (Seed) on January 24, 2025.
  • Sycai Medical raised $3.1M (Seed) on January 23, 2025.
  • Parol raised $1.3M (Seed) on December 12, 2024.
  • Orakl Oncology raised $12M (Seed) on December 3, 2024.

Who to call at Carna, and when

A new round usually means Carna is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Carna raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Carna, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Carna. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Carna

Location

131 Dartmouth Street 3rd Floor

Boston, Massachusetts, United States

About

Carna Health is at the forefront of kidney health innovation, merging groundbreaking technology with a deep commitment to patient care. Our team, driven by a vision to transform global healthcare, develops advanced, yet intuitive, health monitoring solutions. One of the key highlights of our approach is the incorporation of Nova Biomedical handheld creatinine and eGFR (Estimated Glomerular Filtration Rate) devices, a cornerstone of our medical technology. The integration of top-tier tech with a patient-centric approach propels us to notable achievements in the field of nephrology. It redefines the management and monitoring of kidney diseases, enhancing care delivery, and significantly improving the quality of life for patients worldwide.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Carna raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Carna's next move

See what Strategic adds

Carna raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.